Compare POWW & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POWW | CBUS |
|---|---|---|
| Founded | 1990 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.8M | 197.5M |
| IPO Year | N/A | 2017 |
| Metric | POWW | CBUS |
|---|---|---|
| Price | $2.10 | $3.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $2.40 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 729.8K | 539.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,262,000.00 |
| Revenue This Year | $14.56 | N/A |
| Revenue Next Year | $0.50 | $99.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 134.56 |
| 52 Week Low | $1.08 | $1.09 |
| 52 Week High | $2.19 | $3.80 |
| Indicator | POWW | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 62.37 |
| Support Level | $1.62 | $1.34 |
| Resistance Level | $2.14 | N/A |
| Average True Range (ATR) | 0.10 | 0.37 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 63.95 | 76.69 |
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.